包裝量:100iu/ml 3ml/Vial
另外,在不同組織中,胰島素有幾種合成代謝和抗分解代謝的作用。在肌肉和其他組織(腦除外)中,此作用包含增加脂肪酸、甘油和蛋白質合成及胺基酸吸收,然而降低酮體生成、脂肪分解、蛋白質分解代謝和胺基酸排出。在肝臟中,胰島素促進肝醣吸收和貯存、抑制肝醣分解及糖質新生、和促進大量葡萄糖轉換成脂肪。
2.給藥劑量請遵照醫師指示使用。
1.低血糖:是在胰島素治療時最常出現的不愉快作用,低血糖症狀通常會突然發生。
2.一般性的副作用:開始使用胰島素時,可能會發生水腫及視力不正常。這些症狀通常是過渡性質的。
Absorption
C max is about 23 mU/L. T max is about 1 h.
Distribution
0% to 9% bound to plasma proteins.
Elimination
Cl is 1.22 L/h/kg. The half-life is 81 min.
Peak
1 to 3 h.
Duration
3 to 5 h.
Special Populations
Children
Pharmacokinetics in children and adolescents with type 1 diabetes are similar to those of healthy adults and adults with type 1 diabetes.
Obesity Insulin aspart
Cl is reduced 28% in patients with a body mass index (BMI) more than 32 kg/m 2 compared with patients with a BMI less than 23 kg/m 2 .
Alcohol, beta-blockers, clonidine, lithium salts
May potentiate or weaken the blood glucose–lowering effects of insulin.
ACE inhibitors, disopyramide, fenfluramine, fibrates, fluoxetine, MAOIs, octreotide, oral hypoglycemic agents, pentoxifylline, propoxyphene, salicylates, sulfa
antibiotics
May increase hypoglycemic effects of insulin.
Atypical antipsychotics, corticosteroids, danazol, diazoxide, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, protease inhibitors, somatropin, sympathomimetics, thyroid hormone
May decrease hypoglycemic effects of insulin.
Beta-blockers, clonidine, guanethidine, reserpine
Signs of hypoglycemia may be reduced or absent.
Pentamidine
May cause hypoglycemia, which may be followed by hyperglycemia.
2.有合併症及併用藥品之病患或許會因食物作用而造成延遲吸收之效應,因此使用NovoRapid Penfill會快速發揮作用亦應被審慎考慮。合併症,特別是感染發生時,胰島素的需要量會增加。
3.腎臟或肝臟功能不全的患者可能要減少胰島素的需要量。
藥品應置於攝氏 2 ~ 8 度冰箱內(勿冷凍);如發生變質或過期,不可再使用。
已開封使用之藥品,於室溫25℃以下,陰涼乾燥處存放,可使用一個月。超過期限,未用完之藥品,應予丟棄。



